share_log

AstraZeneca | SC TO-C: Written communication relating to an issuer or third party tender offer

Jan 9, 2023 16:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more